Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Morimoto

Showing results (311-320 of 313) with videos related to

Pageof 32
Sort By:
You have reached the last page of results.This site can display upto 313 results.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 17, 2011
Revision of the criteria for Alzheimer’s disease: A symposiumSteven T DeKosky, Maria C Carrillo, Creighton Phelps, et al.
Regulatory Toxicology and Pharmacology : RTP|September 18, 2024
Reevaluating safety pharmacology respiratory studies within the ICH S7A core battery: A multi-company evaluation of preclinical utility and clinical translationG S Friedrichs, M M Abernathy, D Ackley, et al.
The Lancet. Neurology|May 31, 2014
Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2/3 trialAdam L Boxer, Anthony E Lang, Murray Grossman, et al.
Pageof 32

Showing results (311-320 of 313) with videos related to

Sort By:
Pageof 32
You have reached the last page of results.This site can display upto 313 results.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 17, 2011
Revision of the criteria for Alzheimer’s disease: A symposiumSteven T DeKosky, Maria C Carrillo, Creighton Phelps, et al.
Regulatory Toxicology and Pharmacology : RTP|September 18, 2024
Reevaluating safety pharmacology respiratory studies within the ICH S7A core battery: A multi-company evaluation of preclinical utility and clinical translationG S Friedrichs, M M Abernathy, D Ackley, et al.
The Lancet. Neurology|May 31, 2014
Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2/3 trialAdam L Boxer, Anthony E Lang, Murray Grossman, et al.
Pageof 32